Protara Therapeutics, Inc.
TARA • NASDAQ
Protara Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jesse Shefferman, with a market cap of $267.2M.
CEOJesse Shefferman
Next Earnings
Upcoming earnings announcement for Protara Therapeutics, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.36
Earnings History
Past 12 earnings reports for Protara Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Q4 2025 | -$0.37Est: -$0.32 | -15.6% | - | — |  10-K |
| Nov 10, 2025 | Q3 2025 | -$0.31Est: -$0.40 | +22.5% | - | — | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$0.35Est: -$0.40 | +12.5% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.29Est: -$0.48 | +39.6% | - | — | 10-Q |
| Mar 5, 2025 | Q4 2024 | -$0.48Est: -$0.56 | +14.3% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.50Est: -$0.52 | +3.8% | - | — | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.45Est: -$0.80 | +43.8% | - | — | 10-Q |
| May 2, 2024 | Q1 2024 | -$0.97Est: -$0.95 | -2.1% | - | — | 10-Q |
| Mar 13, 2024 | Q4 2023 | -$0.90Est: -$0.92 | +2.2% | - | — | 10-K |
| Nov 3, 2023 | Q3 2023 | -$0.87Est: -$0.98 | +11.2% | - | — | — |
| Aug 3, 2023 | Q2 2023 | -$1.00Est: -$0.87 | -14.9% | - | — | 10-Q |
| May 4, 2023 | Q1 2023 | -$0.80Est: -$0.88 | +9.1% | - | — | — |